Viewing Study NCT02073227


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-06-17 @ 6:58 PM
Study NCT ID: NCT02073227
Status: COMPLETED
Last Update Posted: 2014-09-09
First Post: 2014-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy Volunteers View
None Canagliflozin View
None Metformin View
None Type 2 diabetes mellitus View